NovaPoint Capital’s Palantir PLTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Buy
13,358
+93
+0.7% +$12.7K 0.32% 69
2026
Q1
$1.94M Buy
13,265
+985
+8% +$151K 0.49% 60
2025
Q4
$2.18M Buy
12,280
+779
+7% +$141K 0.56% 56
2025
Q3
$2.1M Buy
11,501
+1,037
+10% +$168K 0.51% 57
2025
Q2
$1.43M Buy
10,464
+891
+9% +$105K 0.44% 58
2025
Q1
$808K Buy
9,573
+467
+5% +$41K 0.25% 78
2024
Q4
$689K Buy
9,106
+2,120
+30% +$123K 0.21% 79
2024
Q3
$260K Buy
+6,986
New +$214K 0.08% 118

Other funds holding PLTR

NovaPoint Capital's PLTR Position: Q2 2026 in Review

NovaPoint Capital increased its Palantir (PLTR) stake by 0.7% in Q2 2026, buying an estimated $12.7K and bringing the position to 13,358 shares worth $1.56M. The position accounts for 0.32% of the portfolio, ranked #69.

NovaPoint Capital first reported a position in PLTR in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.18M in Q4 2025. 2,838 funds tracked by Wall St. Rank hold PLTR as of Q2 2026.

  • NovaPoint Capital held 13,358 shares of Palantir worth $1.56M as of Q2 2026.
  • NovaPoint Capital bought 93 Palantir shares in Q2 2026, an estimated $12.7K.
  • Palantir made up 0.32% of NovaPoint Capital's portfolio in Q2 2026, its #69 holding.
  • NovaPoint Capital first reported a position in Palantir in Q3 2024 and has held it in 8 quarters since.
  • NovaPoint Capital's Palantir position peaked at $2.18M in Q4 2025.
  • 2,838 funds tracked by Wall St. Rank held Palantir as of Q2 2026.

Based on NovaPoint Capital's 13F filing for Q2 2026, filed 6 Aug 2026.